Propanc Biopharma enters amended employment agreement with CEO James Nathanielsz

Propanc Biopharma, Inc.

New base salary of $600,000 AUD per annum, plus salary sacrifice for tuition up to $200,000 AUD.
Annual discretionary bonus reduced to up to 100% of base salary (from 200% previously).
Term of 3 years from July 1, 2022, with automatic yearly renewal unless terminated.
Severance: one year's base salary upon termination without cause or company non-renewal; only accrued amounts if executive non-renewal.
Includes one-year non-compete and indemnification provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.